Masaki Yoda

Masaki Yoda

Auto-generated profile, based on publicly available information

Masaki Yoda

Department of Orthopaedic Surgery, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 January 2010 in Journal of Orthopaedic Research
Verified
Journal Article
Open access
PDF file
KTKosuke Tajima
Kosuke Tajima
HTHironari Takaishi
Hironari Takaishi
JTJiro Takito
Jiro Takito
TTTakahide Tohmonda
Takahide Tohmonda
MYMasaki Yoda
Masaki Yoda
YTYoshiaki Toyama
Yoshiaki Toyama
Skeletal fracture healing involves a variety of cellular and molecular events; however, the mechanisms behind these processes are not fully understood. In the current study, we investigated the potential involvement of the signal transducer and activator of transcription 1 (STAT1), a critical regulator for both osteoclastogenesis and osteoblast differentiation, in skeletal fracture healing. We used a fracture model and a cortical defect model in mice, and found that fracture callus remodeling and membranous ossification are highly accelerated in STAT1‐deficient mice. Additionally, we found that STAT1 suppresses Osterix transcript levels and Osterix promoter activity in vitro, indicating the suppression of Osterix transcription as one of the mechanisms behind the inhibitory effect of STAT1 on osteoblast differentiation. Furthermore, we found that fludarabine, a potent STAT1 inhibitor, significantly increases bone formation in a heterotopic ossification model. These results reveal previously unknown functions of STAT1 in skeletal homeostasis and may have important clinical implications for the treatment of skeletal bone fracture. © 2010 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 28:937–941, 2010

1 May 2020 in Bone
Verified
Journal Article
Closed access
SMSakiko Mizuno
Sakiko Mizuno
MYMasaki Yoda
Masaki Yoda
TKTokuhiro Kimura
Tokuhiro Kimura
MSMasayuki Shimoda
Masayuki Shimoda
HAHaruhiko Akiyama
Haruhiko Akiyama
KHKeisuke Horiuchi
Keisuke Horiuchi

1 September 2024 in Development
Verified
Journal Article
Open access
YKYukiko Kuroda
Yukiko Kuroda
MYMasaki Yoda
Masaki Yoda
KKKatsuhiro Kawaai
Katsuhiro Kawaai
MTMotoharu Tatenuma
Motoharu Tatenuma
TMToshihide Mizoguchi
Toshihide Mizoguchi
KMK. Matsuo
K. Matsuo
Developing long bones alter their shape while maintaining uniform cortical thickness via coordinated activity of bone-forming osteoblasts and bone-resorbing osteoclasts at periosteal and endosteal surfaces, a process we designate trans-pairing. Two types of trans-pairing shift cortical bone in opposite orientations: peri-forming trans-pairing (peri-t-p) increases bone marrow space and endo-forming trans-pairing (endo-t-p) decreases it, via paired activity of bone resorption and formation across the cortex. Here, we focused on endo-t-p in growing bones. Analysis of endo-t-p activity in the cortex of mouse fibulae revealed osteoclasts under the periosteum compressed by muscles, and expression of RANKL in periosteal cells of the cambium layer. Furthermore, mature osteoblasts were localized on the endosteum, while preosteoblasts were at the periosteum and within cortical canals. X-ray tomographic microscopy revealed the presence of cortical canals more closely associated with endo- than with peri-t-p. Sciatic nerve transection followed by muscle atrophy and unloading induced circumferential endo-t-p with concomitant spread of cortical canals. Such canals likely supply the endosteum with preosteoblasts from the periosteum under endo-t-p, allowing bone shape to change in response to mechanical stress or nerve injury.

16 April 2026 in PLOS ONE
Verified
Journal Article
Open access
SMSatoru Morikawa
Satoru Morikawa
MYMasaki Yoda
Masaki Yoda
Takehito OuchiTakehito Ouchi
Takehito Ouchi
TYTakazumi Yasui
Takazumi Yasui
KFKazumasa Fukuda
Kazumasa Fukuda
YNYasuhide Nakayama
Yasuhide Nakayama
Driven by endogenous platelet-derived growth factor receptor α (PDGFRα)-positive cells, in-body tissue architecture (iBTA) enables the autonomous formation of vascularized tissues within subcutaneously implanted molds, overcoming the limitations of traditional cell therapies. The cellular mechanisms were investigated in PDGFRα reporter mice. Recruited PDGFRα-lineage cells were closely associated with Pecam-1-positive vessels and often adopted perivascular positions. Flow cytometry revealed that these cells expressed the mesenchymal stem/stromal cell (MSC) markers (CD73, CD90, and CD105). Additionally, the cultured isolates maintained MSC morphology and demonstrated osteogenic, chondrogenic, and adipogenic differentiation potential in vitro. The approach was successfully scaled to a porcine model, which exhibited organized tissue maturation, including vascular structures and collagen deposition, within 2 weeks. iBTA eliminates the need for cell isolation and immunosuppression by leveraging resident PDGFRα-positive MSCs for in situ tissue generation, providing a direct pathway for autologous vascular tissue engineering applications.